As part of our LiveTalk series, Being Patient sat down with Bree Baldwin, aging life care manager at Debra Levy Associates, to discuss ways…
Now under review, the drug pimavanserin may become the first FDA-approved treatment for dementia-related psychosis. Roughly 2.4 million Americans experience symptoms of dementia-related psychosis,…
For families including those with loved ones who have dementia, navigating the system of conservatorship can be daunting. In November 2020, a Los Angeles…
As part of our LiveTalk series, Being Patient spoke with Psychologist Dale Atkins, co-author of “The Kindness Advantage,” about ways for caregivers to find…
New research paves the way for a future in which concussions — which are often missed — could be detected on the spot with…
While Biogen’s experimental Alzheimer’s treatment aducanumab faced yet another snag recently in its convoluted path toward FDA approval, other drugs companies are catching up:…
As part of our BrainTalk series, Being Patient spoke with Executive Director of ACADIA Pharmaceuticals Dr. Erin Foff and Chris Schwilk, who lives with…